Atlas Trials

Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration

Clinical trial NCT02862938 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02862938
Sponsor
Stanford University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Glaucoma
Start date
2016-06-01
Primary completion
2025-08-15
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.